F 0697
Provide safe, appropriate pain management for a resident who requires such services.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review the facility failed to ensure that pain management was provided to
residents who required such services, consistent with professional standards of practice, the
comprehensive person-centered care plan, and the residents' goals and preferences for 1 of 4 residents
(Resident #1) reviewed for pain management.
Residents Affected - Few
The facility failed to ensure Resident #1 received scheduled hydrocodone as ordered from 03/29/24 to
03/31/24.
This failure placed residents at risk of increased pain and decreased quality of life.
Findings included:
Review of the undated face sheet for Resident #1 reflected a [AGE] year-old female admitted to the facility
on [DATE] with diagnoses including pain in left shoulder, contracture of left elbow, hip, and knee and right
elbow, hip, and knee, osteoarthritis, generalized anxiety disorder, chronic pain syndrome, and rheumatoid
arthritis.
Review of the admission MDS assessment for Resident #1 dated 03/12/24 reflected a BIMS score of 15,
indicating she was cognitively intact. It reflected she was on a scheduled pain regimen. It reflected she had
not experienced pain in the five days prior to the assessment. It also reflected she was taking opioid pain
medication . It reflected she required total or substantial assistance in all ADLs except eating and oral
hygiene, with which she required only partial assistance.
Review of the care plan for Resident #1 dated 02/29/24 reflected the following: The resident is on pain
medication
therapy HYDROcodone-Acetaminophen Oral Tablet 10-325 MG) r/t chronic pain. The resident will be free of
any
discomfort or adverse side effects from pain medication through the review date. Administer ANALGESIC
medications as ordered by physician. Monitor/document side effects and effectiveness Q-SHIFT.
Monitor/document/report PRN adverse reactions to analgesic therapy: altered mental status, anxiety,
constipation, depression, dizziness, lack of appetite, nausea, vomiting, pruritus, respiratory
distress/decreased respirations, sedation, urinary retention.
Review of physician orders for Resident #1 dated 02/28/24 reflected the following:
HYDROcodone-Acetaminophen Oral Tablet 10-325 MG (Hydrocodone-Acetaminophen) Give 2 tablet by
mouth two times a day
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
676180
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
676180
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/04/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Elgin Nursing and Rehabilitation Center
1373 North Avenue C
Elgin, TX 78621
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0697
for chronic pain.
Level of Harm - Minimal harm
or potential for actual harm
Review of the March 2024 MAR for Resident #1 reflected the 09:00 AM and 09:00 PM administrations were
marked 9, indicated on the MAR key by 9=Other / See Progress Notes. These administrations were signed
by MA B.
Residents Affected - Few
Review of the progress notes for Resident #1 from 03/29/24 to 03/31/24 reflected the following notes:
03/29/24 01:02 PM Note Text: (np) called and updated to reorder norco 10-325mg to pharmacy.
03/31/24 03:12 AM Acetaminophen Oral Tablet 325 MG Give 2 tablet by mouth every 4 hours as needed for
pain/fever 2 tabs to = 650mg, to not exceed more than 3 grams from all sources in a 24hr period.
03/31/24 05:56 AM Acetaminophen Oral Tablet 325 MG Give 2 tablet by mouth every 4 hours as needed for
pain/fever 2 tabs to = 650mg, to not exceed more than 3 grams from all sources in a 24hr period PRN
Administration was: Effective
Follow-up Pain Scale was: 0.
03/31/24 10:54 AM Acetaminophen Oral Tablet 325 MG Give 2 tablet by mouth every 4 hours as needed for
pain/fever 2 tabs to = 650mg, to not exceed more than 3 grams from all sources in a 24hr period.
03/31/24 03:09 PM Acetaminophen Oral Tablet 325 MG Give 2 tablet by mouth every 4 hours as needed for
pain/fever 2 tabs to = 650mg, to not exceed more than 3 grams from all sources in a 24hr period PRN
Administration was: Effective
Follow-up Pain Scale was: 0.
03/31/24 08:44 PM HYDROcodone-Acetaminophen Oral Tablet 10-325 MG Give 2 tablet by mouth two
times a day for chronic pain. Pending delivery from the pharmacy.
Review of administrations from the facility emergency kit reflected Resident #1 was given 2 tablets of
hydrocodone at 09:40 PM on 03/28/24 and that LVN A signed out the dose. There were no other
administrations recorded for her after that.
Review of pain assessments for Resident #1 from 03/29/24 to 03/31/24 reflected she was assessed three
times per day (day shift, evening shift, and overnight shift) for pain and reported a pain level of 0 each time,
indicating she was in no pain. The dayshift and evening shift assessments for 03/30/24 and 03/31/24 were
conducted by LVN A.
Observation and interview on 04/04/24 at 02:06 PM revealed Resident #1 laying in bed under blankets. She
was calm and stated she was comfortable. She stated she had experienced an issue with her pain
medications the previous weekend from Friday 03/29/24 to 03/31/24. She stated her usual hydrocodone
was white, and on Thursday night 03/28/24, she received a dose that was blue. Resident #1 stated she
thought it was unusual, but it did not concern her. She stated she looked up the number printed on the pills
that evening and saw they were hydrocodone, so she took them. She stated the following morning,
03/29/24, she should have received another dose, but MA B told her the pills had not arrived from the
pharmacy. She stated she went through the whole weekend with MA B telling her the pills
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
676180
If continuation sheet
Page 2 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
676180
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/04/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Elgin Nursing and Rehabilitation Center
1373 North Avenue C
Elgin, TX 78621
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0697
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
were not available. She stated she started to feel poorly; her legs were irritated, and she was sweaty. She
stated she was always in pain due to her rheumatoid arthritis, and she had been on the hydrocodone for 13
years. She stated the medications did not do a lot for her pain, but she was used to having them. She
stated she felt strange, so she did not know if she was going through withdrawal. She stated the nurse
came in and checked her vital signs, which were fine. Resident #1 stated she did not say anything to the
nurse about the missing medication, because Resident #1 figured if MA B knew, the nurse must have
known. Resident #1 stated all day Sunday she was very hot and sweaty, and finally she asked LVN A what
was going on with her hydrocodone. Resident #1 stated LVN A then reached out and took care of the issue,
and the hydrocodone came in that night. Resident #1 stated she received a dose around 10:00 PM on
Sunday night 03/31/24.
An interview was attempted on 04/04/24 at 02:23 PM with MA B. A voicemail was left but no return contact
occurred as of 04/11/24.
During an interview on 04/04/24 at 03:40 PM, LVN A stated she conducted several pain assessments for
Resident #1 from 03/29/24 to 03/31/24, and Resident #1 never communicated that she was in pain. LVN A
stated she did not see any nonverbal signs of pain during that time: no tremors, sweating, nausea, or
anything that would indicate distress. LVN A stated LVN A had called the NP on the night of 03/28/24 and
requested the hydrocodone be refilled. LVN A stated she also pulled a hydrocodone from the emergency kit
that evening for Resident #1. LVN A stated she did not work on Friday 03/29/24. LVN A stated when she
returned on 03/30/24, she assumed the medication had arrived, because Resident #1 did not complain,
and the medication aide did not report any unavailable medications to her. LVN A stated it was not until late
Sunday morning that Resident #1 told LVN A she had a bad night the night before and told her she had not
received her hydrocodone since the previous Thursday night 03/28/24 that LVN A realized the medication
was still unavailable. LVN A stated she called the pharmacy and learned they had not received the request
from the weekday NP yet. LVN A stated she then called the on call NP who sent a triplicate request form to
the pharmacy, and the medication was delivered later that night. LVN A stated the administration record
reflected that Resident #1 was administered Tylenol on 03/30/24 and 03/31/24. LVN A stated she did not
know why the nurse on duty 03/30/24 had not administered any doses of the medication from the
emergency kit. LVN A stated she did not, because she did not know the medication was unavailable until
mid-day 03/31/24.
During an interview on 04/04/24 at 04:14 PM, the ADON stated the IDt had been aware Resident #1's
hydrocodone had not come in during their morning meeting on 03/29/24, and she had asked LVN C to
follow up with the pharmacy and the NP to find out what was going on. The ADON stated she did not find
out if LVN C followed up or what the result was, and the ADON was just now finding out that Resident #1
went without her hydrocodone all weekend. The ADON stated they ensured residents had the medications
they needed for pain management, because they had and emergency kit. The ADON stated they pulled
reports that let them know if something was missing, but because it was the weekend, there was no one
present to pull the report. She stated they had no process during the weekend to oversee if medications
were unavailable and relied on the staff to report verbally so they could get the medications that were
needed. She stated she and the DON were both responsible for ensuring the residents had their scheduled
medications available. The ADON stated without available hydrocodone, a resident could go with
uncontrolled pain.
During an interview on 04/04/24 04:45 PM, the DON stated the first point of contact/responsible person for
ensuring residents had their pain medications available was the charge nurse. The DON stated the
managers reviewed a report each weekday morning to address any issues or missing medications, but on
weekends, it was up to the charge nurses on duty to monitor that system. She stated she
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
676180
If continuation sheet
Page 3 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
676180
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/04/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Elgin Nursing and Rehabilitation Center
1373 North Avenue C
Elgin, TX 78621
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0697
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
ensured the staff were compliant with their system by training them to communicate when something is
wrong. The DON stated the staff knew they had to give the medications and follow orders, and if the
medications were not available, they knew they had to communicate directly for each missed
administration. She stated it was also their policy to reorder medications well ahead of time: the aides
needed to let the nurses know to reorder, and the nurses needed to do the reordering. The DON stated
Resident #1's hydrocodone was scheduled, and there must have been a communication lapse from MA B
to the nurses on duty those days. The DON stated a potential negative outcome of the failure was residents
would be uncomfortable and would not feel very comfortable.
Review of in-services from January 2024 to March 2024 reflected the following:
Medication Administration 03/07/24
Medication Administration 03/14/24
Medication Administration 03/19/24
Medication Administration 03/26/24
Review of the facility policy dated 08/15/22 and titled Pain Management reflected the following: The facility
must ensure that pain management is provided to residents who require such services, consistent with
professional standards of practice, the comprehensive person-centered care plan, and the residents' goals
and preferences. The facility will utilize a systematic approach for recognition, assessment, treatment, and
monitoring of pain.
Review of facility policy dated 10/24/22 and titled Medication Administration reflected the following:
Medications are administered by licensed nurses, or other staff who are legally authorized to do so in the
state, as ordered by the physician and in accordance with professional standards of practice, in a manner
to prevent contamination or infection.
Review of facility policy dated 10/01/19 and titled Ordering and Receiving Medications from Pharmacy
reflected the following: It will be the responsibility of the facility to re-order the medication to avoid any lapse
in therapy. And Controlled substances are re-ordered a five-day supply remains to allow for transmittal of
the required written prescription to the pharmacist.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
676180
If continuation sheet
Page 4 of 4